NFKB1 and asthma: In a murine model of asthma, AS-IV inhibited the production of proinflammatory cytokines and chemokines by inflammatory cells and ameliorated the immune response [24], and in a rat model of acute ischemic kidney injury AS-IV mediated the inflammatory response by inhibiting NF-κB expression [25].